Archive · 20 Aug 2025
Welcure Drugs & Pharma Stock Hits 5% Upper Circuit
Welcure Drugs & Pharmaceuticals, a company that makes medicines, saw its stock price go up quickly.
This happened after the company said it will build a lab to make medicines from plants.
The new lab will cost around 70-80 crore rupees.
The company wants the lab to meet high standards so they can sell their products in other countries.
The stock price went up 5% because of the announcement.
Welcure Drugs & Pharmaceuticals saw its share price hit a 5% upper circuit.
The share price opened at ₹12.70 on the BSE, 5% higher than the previous day.
The company announced plans for an Agro-Pharma Research Laboratory on August 20.
The laboratory aims to develop pharmaceutical-grade products from agricultural inputs.
The project's estimated cost is ₹70-80 crore and will adhere to cGMP standards.
- Who
- Welcure Drugs & Pharmaceuticals.
- What
- Welcure Drugs & Pharmaceuticals' share price increased by 5% due to the announcement of a new agro-pharma research laboratory.
- When
- The share price increase occurred during the intraday trades on Wednesday.
- Where
- The stock price was observed on the BSE.
- Why
- Due to the announcement of a new agro-pharma research laboratory.
- Company
- Welcure Drugs & Pharmaceuticals Ltd.
- Share Price Movement
- 5% upper circuit
- Opening Price
- ₹12.70
- Previous Closing Price
- ₹12.10
- Project
- Agro-Pharma Research Laboratory
- Project Cost
- ₹70-80 crore
- Focus
- Converting agricultural/botanical inputs into pharmaceutical-grade products
